AURUM VENTURES MKI
Aurum Ventures MKI provides value added growth capital to exceptional entrepreneurs within the fields of life-sciences and clean-tech. While we focus on investing in unique, cutting edge technologies that will mature into successful business companies, our investments reflect our own values, so we prefer investing in companies that, through their sound commercial propositions, also contribute to the well-being of mankind. Our team is comprised of senior and experienced hands-on executives who work actively with the portfolio companies in enhancing their strategic and execution capabilities. We typically take a long-term approach, understanding that ventures in the life sciences and clean tech take time to mature and be successful.
AURUM VENTURES MKI
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GStatic Google Static Content
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
FIRST
FIRST aims to inspire young people to be science and technology leaders.
Current Employees Featured
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-02-09 | Scopio Labs | Aurum Ventures MKI investment in Series C - Scopio Labs | 50 M USD |
2018-11-18 | KidneyCure | Aurum Ventures MKI investment in Venture Round - KidneyCure | 4 M USD |
2016-05-24 | Nucleix | Aurum Ventures MKI investment in Seed Round - Nucleix | 3 M USD |
2015-08-05 | LifeBond | Aurum Ventures MKI investment in Series D - LifeBond | 27 M USD |
2009-03-01 | CorAssist | Aurum Ventures MKI investment in Venture Round - CorAssist | 5.25 M USD |
2007-04-19 | BPT | Aurum Ventures MKI investment in Series A - BPT | 2.5 M USD |